Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00034047 · ClinicalTrials.gov registry record · Phase 1

Endometriosis : Traditional Medicine vs Hormone Therapy

A Phase 1 study of Endometriosis and Pelvic Pain, sponsored by National Center for Complementary and Integrative Health (NCCIH).

Completed
Registry status
Phase 1
Development phase
50
Enrollment target
2
Study locations

NCT00034047 is a Phase 1 study of Endometriosis and Pelvic Pain that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 50 participants, below the 263-participant average among 48 other Endometriosis trials with a reported enrollment target (81% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00034047, a Phase 1 study of Endometriosis and Pelvic Pain, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).

COMPLETED
Registry status
Phase 1
Development phase
50 participants
Enrollment target
2
Study locations

Study Summary

This 36-week study will determine whether traditional Chinese medicine (acupuncture and Chinese herbs) is as effective as hormone therapy for alleviating endometriosis-related pelvic pain.

Interventions

  • PROCEDURE Acupuncture
  • DRUG Chinese Products
  • DRUG Nafarelin

Study Locations (2)

Oregon

  • Oregon Health Sciences University, Women's Health Research Unit - Portland
  • Oregon College of Oriental Medicine Clinic - Portland

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2002-09
Est. Completion 2006-08
Phase Phase 1

What the Registry Record Tells You About NCT00034047

The ClinicalTrials.gov registry entry for NCT00034047 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 263-participant average among 48 other Endometriosis trials with a reported enrollment target (81% lower). The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Endometriosis appearing as the primary indexed condition, and to 3 interventions - of which Acupuncture is the first listed.

NCT00034047 reports 2 study locations spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT00034047 about?

NCT00034047 is a clinical study titled "Endometriosis : Traditional Medicine vs Hormone Therapy". This 36-week study will determine whether traditional Chinese medicine (acupuncture and Chinese herbs) is as effective as hormone therapy for alleviating endometriosis-related pelvic pain.

What is the current status of trial NCT00034047?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2002-09. Estimated completion is 2006-08.

What conditions does trial NCT00034047 study?

This clinical trial studies the following conditions: Endometriosis, Pelvic Pain.

What interventions are being tested in trial NCT00034047?

The interventions under investigation include: Acupuncture (PROCEDURE), Chinese Products (DRUG), Nafarelin (DRUG).

Who is sponsoring clinical trial NCT00034047?

This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00034047 being conducted?

This trial has 2 study locations across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Endometriosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.